SCHEMBL5320628

SCHEMBL5320628

O=C(C(=O)c1ccc[nH]1)c1ccc[nH]1

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.54
▸ CYP2D6 P10635 10/20 0.48
▸ CYP1A2 P05177 8/20 0.48
▸ CYP1B1 Q16678 5/20 0.48
▸ CYP1A1 P04798 3/20 0.47
▸ LMNA P02545 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ AHR P35869 1/20 0.47
▸ ATM Q13315 1/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ MAOB P27338 2/20 0.44
▸ MAOA P21397 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1127485 0.87 TSHR (0.53) TSHRCYP2D6CYP1A2MAPTATM
SCHEMBL29137674 0.85 TSHR (0.47) TSHRCYP2D6CYP1A2NPC1RAB9A
SCHEMBL1127202 0.85 TSHR (0.47) TSHRCYP2D6CYP1A2CYP1B1CYP1A1
SCHEMBL1126578 0.85 TSHR (0.47) TSHRCYP2D6CYP1A2CYP1B1LMNA
SCHEMBL371069 0.83 TSHR (0.54) TSHRCYP2D6CYP1A2CYP1B1LMNA
SCHEMBL9853987 0.82 RAB9A (0.49) TSHRCYP2D6MAPTATMMEN1
SCHEMBL302811 0.81 — —
SCHEMBL10141202 0.81 — —
SCHEMBL28298 0.81 — —
SCHEMBL21114388 0.81 TSHR (0.57) TSHRCYP2D6CYP1A2MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112358493-B Micromolecular photothermal reagent based on boron-fluorine complex and preparation method and application thereof 南京林业大学 2022-06-21 — — CN claimed
CN-102241672-A 2,3-dipyrrolyl-6-acylaminoquinoxaline compounds and preparation method thereof UNIVTAISHAN MEDICAL 2011-11-16 — — CN disclosed
CN-101671289-B Preparation method of 1, 2-di(2-pyrryl)-ethyldione XUEMEI ZHAO 2011-08-10 — — CN disclosed
CN-101671289-B Preparation method of 1, 2-di(2-pyrryl)-ethyldione XUEMEI ZHAO 2011-08-10 — — CN disclosed
CN-101671289-A Preparation method of 1, 2-di(2-pyrryl)-ethyldione XUEMEI ZHAO 2010-03-17 — — CN disclosed
CN-101671289-A Preparation method of 1, 2-di(2-pyrryl)-ethyldione XUEMEI ZHAO 2010-03-17 — — CN disclosed
WO-2007121853-A2 LIGHTENING AND/OR COLOURING AGENTS COMPRISING N,N'-OXALYLDIAZOLES AND/OR OXIMIDYLDIAZOLES HENKEL AG & CO. KGAA (DE) 2007-11-01 — — WO disclosed
US-20030162960-A1 Colormetric sensor compositions and methods NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-08-28 — — US disclosed
US-6482949-B1 Colormetric sensor compositions and methods NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-11-19 — — US disclosed
EP-0596876-A1 CHELATOR COMPOSITIONS COMPRISING ALPHA-DIAMINE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 1994-05-18 — — EP disclosed
EP-0596876-A4 CHELATOR COMPOSITIONS COMPRISING ALPHA-DIAMINE COMPOUNDS. PROCTER & GAMBLE (US) 1993-03-01 — — EP disclosed
WO-1991016035-A1 CHELATOR COMPOSITIONS COMPRISING ALPHA-DIAMINE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 1991-10-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162960-A1 Colormetric sensor compositions and methods PAH, NISCH, SPR TSHR 1412/4885CYP2D6 1426/4885CYP1A2 1387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback